🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
The purpose of this study is to demonstrate the impact of secukinumab on th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-11-30
Trial ID
NCT03259074
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Arizona Arthritis and Rheumatology Associates PLLC
Start Date
2023-03-22
Trial ID
NCT05767034
Treatments Being Tested
The purpose of this extension study is to evaluate maintenance of Hidradeni...
Status
Completed
Location
Northwest Arkansas Center
Start Date
2020-03-18
Trial ID
NCT04179175
Treatments Being Tested
The purpose of the present study was to assess the efficacy of secukinumab ...
Status
Terminated
Location
Millennium Clinical Trials
Start Date
2023-08-10
Trial ID
NCT05722522
Treatments Being Tested
To demonstrate that the efficacy of secukinumab 300 mg at Week 16 was super...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-27
Trial ID
NCT02798211
Treatments Being Tested
This was a pivotal, randomized, double-blind, placebo-controlled trial eval...
Status
Terminated
Location
University Of Alabama
Start Date
2020-07-07
Trial ID
NCT04181762
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of secukinumab ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-30
Trial ID
NCT03765788
Treatments Being Tested